EMBOL··X, created in 1999 (United States), from 150 sister brands and 2279 competing brands. The EMBOL··X brand is owned by Edwards Lifesciences, a company listed in New York. EMBOL··X is part of the Medical Devices & Instruments activity sector.

Share price and profitability of the share Edwards Lifesciences (EMBOL··X)

Buy Edwards Lifesciences share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 95.56

Portfolio valuation
Edwards Lifesciences (EMBOL··X) over 5 years* USD 143.80

Stock market history Edwards Lifesciences (EMBOL··X)